No Data
No Data
Biosimilars Market Industry Trends and Global Forecasts to 2035, Featuring Amgen, BIOCAD, Biocon, Celltrion, Coherus BioSciences, Eli Lilly, Fresenius Kabi, Pfizer, Sandoz and Teva Pharmaceuticals - ResearchAndMarkets.com
TD Cowen Reaffirms Their Buy Rating on Coherus Biosciences (CHRS)
Coherus BioSciences Price Target Raised to $6.00/Share From $4.00 by Baird
Coherus BioSciences Is Maintained at Outperform by Baird
Coherus Biosciences Announces Board Member Resignation
Coherus BioSciences, Inc.'s (NASDAQ:CHRS) Share Price Boosted 137% But Its Business Prospects Need A Lift Too
AhmadFH : Thanks Jag
71580478 : love it, thanks! what do you think about SHIM?
JMK47 : thanks for all your effort
101628821 : Is it going to melt or continue to rise today?
101821671 : Do you have any opinions on the stock symbol SOAR?
View more comments...